Generic Name |
CP-751,871 + RAD001 | |
---|---|---|
IND |
||
Brand Name (US) |
||
Manufacturer |
||
Drug Type |
||
Delivery |
||
Approval Status |
Discontinued? | |
Indications |
||
Overall Strategy |
Oncogenic Signal Path Based | |
Strategy |
Block related tumor signal paths | |
Drug Category |
IGF1R inhibitor + mTOR Inhibitor |
Links |
|
Trials of this drug |
|
|
RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms |
Trial results |